Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

After a twitching pinky finger led to a diagnosis of young-onset Parkinson’s disease, Keith Krehbiel, then 42, stopped at a bookstore on the way home to learn more about the progressive neurological ...

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

While deep-brain stimulation has been available ... receiving the feature the same day. Medtronic said more than 40,000 patients worldwide with Percept devices may be eligible for the therapy.

With more than 40,000 DBS patients served worldwide with Medtronic Percept™ devices, BrainSense™ Adaptive DBS presents the largest commercial launch (by several magnitudes) of BCI technology ...

executive vice president and president of the Medtronic Neuroscience Portfolio. The medical device company has enhanced its Percept DBS neurostimulators with exclusive BrainSense Adaptive ...

On Feb 24, the FDA approved Medtronic’s BrainSense Adaptive deep brain stimulation, a device that surgeons implant in patients’ chests with electrodes connecting to the brain. The system is ...

China's economy tsar, Vice Premier He Lifeng, sought to reassure foreign CEOs of the country's business potential, describing the economy as highly resilient, while global investment banks ...

With more than 40,000 DBS patients served worldwide 3 with Medtronic Percept devices, BrainSense Adaptive DBS presents the largest commercial launch (by several magnitudes) of BCI technology - ever.